Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders

Reproductive BioMedicine Online

Volumn 19, Issue 4, 2009, Pages 508-513

  Sönmezer, Murat ^a   Ozmen B ^a   Cil A P ^b   Ozkavukcu S ^a   Tasci T ^a   Olmus H ^c   Atabekoglu C S ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

DHEA supplementation; GnRH antagonist; ICSI; Poor ovarian response

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PRASTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OVARY CYCLE; OVARY FOLLICLE CELL; OVARY FOLLICLE MATURATION; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 70449127166     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.06.006     Document Type: Article

References (22)

1. Barad D, Gleicher N 2006 Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Human Reproduction 21, 2845-2849. (Pubitemid 44566996)
2. Barad D, Gleicher N 2005 Increased oocyte production after treatment with dehydroepiandrosterone. Fertility and Sterility 84, 756.
3. Barad D, Brill H, Gleicher N 2007 Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian reserve. Journal of Assisted Reproduction and Genetics 24, 629-634.
4. Casson PR, Lindsay MS, Pisarska MD et al. 2000 Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction 15, 2129-2132.
5. Casson PR, Carson SA, Buster JE et al. 1998 Replacement dehydroepiandrosterone in elderly: rationale and prospects for the future. Endocrinologist 8, 187-194. (Pubitemid 28265096)
6. Casson PR, Santoro N, Elkind-Hirsch K et al. 1998 Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six month trial. Fertility and Sterility 70, 107-110. (Pubitemid 28294631)
7. de Leo V, Lanzetta D, D'Antona D et al. 1998 Hormonal effects of flutamide in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 99-102.
8. Gleicher N, Barad D 2006 Ovarian age-based' stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization. Fertility and Sterility 86, 1621-1625.
9. Gleicher N, Ryan E, Weghofer A et al. 2008 Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished ovarian reserve: a multicenter study. Fertility and Sterility 90(Suppl. 1), S258.
10. Gleicher N, Weghofer A, Barad D 2007 Increased euploid embryos after supplementation with dehydroepiandrosterone (DHEA) in women with premature ovarian aging. Fertility and Sterility 88(Suppl. 1), S232.
11. Haning Jr R, Hackett R, Flood C et al. 1993 Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. Journal of Clinical Endocrinology and Metabolism 76, 1301-1307. (Pubitemid 23155454)
12. Harlow CR, Hillier SG, Hodges JK 1986 Androgen modulation of follicle-stimulating hormone induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 119, 1403-1405.
13. Hillier SG, De Zwart FA 1981 Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro. Endocrinology 109, 1303-1305.
14. Hugues JN, Durnerin IC 2005 Impact of androgens on fertility - physiological, clinical and therapeutic aspects. Reproductive BioMedicine Online 11, 570-580.
15. Mamas L, Mamas E 2009 Premature ovarian failure and dehydroepiandrosterone. Fertility and Sterility 91, 644-646.
16. Orentreich N, Brind JL, Rizcr RL et al. 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 59, 551-555.
17. Ryan E, Claessens EA, Blanco Mejia S 2008 The sex ratio of offspring born to women, using dehydroepiandrosterone (DHEA) to improve ovarian response. Fertility and Sterility 88(Suppl. 1), S116.
18. Siristatidis CS, Hamilton MP 2007 What should be the maximum FSH dose in IVF/ICSI in poor responders? Journal of Obstetrics and Gynaecology 27, 401-405.
19. Vendola K, Zhou J, Wang J et al. 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biology of Reproduction 61, 353-357. (Pubitemid 29344748)
20. Vendola K, Zhou J, Adesanya OO et al. 1998 Androgens stimulate early stages of follicular growth in the primate ovary. Journal of Clinical Investigation 101, 2622-2629. (Pubitemid 28294570)
21. Wachs DS, Coffler MS, Malcom PJ et al. 2008 Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 93, 1827-1833.
22. Weil SJ, Vendola K, Zhou J et al. 1998 Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. Journal of Clinical Endocrinology and Metabolism 83, 2479-2485. (Pubitemid 28503050)